Square Pharmaceuticals

Income Statement

Turnover (Net of VAT)

Cost of Goods Sold
Gross profit

Operating Expense
Administrative Expenses
Selling and Distribution Expenses

Operating Profit
Financial Expenses
Profit From Operation
Contribution to WPPF and Welfare Fund
Net Profit Before Tax
Income Tax Expenses
Current Tax
Deferred Tax

Net Profit After Tax

(DSE Data)
Marlet price per share
Number of share outstanding
Earnings Per Share (EPS)

Square Pharmaceuticals
Ratio Analysis
 Square Pharmaceuticals
Ratio Analysis

Liquidity Ratios
Current Ratio x
Quick Ratio x
Asset Management Ratios
Inventory Turnover x
Recievable Turnover/Average Collection Period Days
Average Payment Period Days
Total Asset Turnover x
Fixed Asset Turnover x
Profitability Ratios
Gross Profit Margin %
Operating Profit Margin %
Net Profit Margin %
Basic Earnings Power (BEP) %
Return on Asset (ROA) %
Return on Equity (ROE) %
Earnings Per Share (EPS) x
Debt Management Ratios
Debt Ratio %
Times Interest Earned (TIE) x
Market Ratios
Price/Earnings Ratio (P/E) x
Market to Book Ratio (M/B) x
Square Pharmaceuticals
Income Statement

2018 2019

52,926,218,655 50,866,867,352
-19,711,065,988 -22,536,669,960
28,974,589,826 23,339,778,881

-7,749,309,449 -8,602,829,820
-1,189,514,648 -1,022,766,391
-6,603,747,456 -7,382,790,764

44,517,161,379 40,348,165,856

11,225,280,377 14,736,949,061
-791,921,561 -859,269,098
16,997,582,524 15,660,887,890
-4,229,408,325 -3,940,193,051
-4,251,005,177 -3,876,979,330
21,596,852 -63,213,721

8,219,525,804 10,562,863,531

2018 2019
30-Jun 30-Jun
222.6 223.32
886,451,011 886,451,011
15.72 16.03

Square Pharmaceuticals
Ratio Analysis
 Square Pharmaceuticals
Ratio Analysis

2018 2019

Current Asset/Current Liabilities 4.91 12.93

(Current Asset – Inventories)/Current Liabilities 4.25 11.38

COGS/Inventory $ (5.41) (4.90)

Receivables / Annual sales/365 10.95 11.21
Payables / Annual purchases/365 81.75 11.48
Sales/Total Assets 0.99 0.78
Sales/Net Fixed Asset 2.03 1.90

Gross profit/ Sales 54.75% 45.88%

EBIT/ Sales 84.11% 79.32%
Net Income After Tax / Net Sales 15.53% 20.77%
EBIT/Total Assets 83.48% 62.02%
Net Income After Tax / Total Assets 15.41% 16.24%
Net Inc. After Tax/Stockholders Equity 18.55% 18.76%
N.I/ number of share of common stock outstanding 15.72 16.03

Total debt / Total assets 12.50% 6.54%

EBIT / Interest expense 5.14 7.51

Mkt. Price Per Share/EPS 14.16 13.93

Market price per share/Book value per share 4.45 3.52
 Square Pharm
Balance

2020

58,346,258,281 ASSETS:
-24,800,035,555 Non-Current Assets
25,902,993,347 Property, Plant and Equipment

-9,776,875,140
-1,226,459,468 Current Assets
-1,212,389,213 Inventories
Trade and Other Receivables
38,118,717,168 Advances, Deposits and Prepayments
Cash and Cash Equivalents
16,126,118,207
-937,796,627 Total Assets:
18,755,932,542
-4,012,667,932 EQUITY & LIABILITIES:
-4,187,481,946 Shareholders’ Equity
174,814,014 Share Capital
Tax Holiday Reserve
12,955,973,632 Genaral Reserve
Retained Earnings
Share Premium

Non-Current Liabilities
Deferred Tax Liabilities
2020
28-Jun
164.29 Current Liabilities
886,451,011
15.82 Trade Creditors
Liabilities for Other Finance
Liabilities for Expenses
Unclaimed Dividend

Total Equity and Liabilities

Net Asset Value (NAV) Per Share

2020

14.52
12.76

(4.36)
9.51
7.96
0.78
2.12

44.40%
65.33%
22.21%
51.27%
17.43%
19.65%
15.82

5.97%
5.92

10.38
2.21
 Square Pharmaceuticals
Balance Sheet

2018 2019 2020

26,132,724,160 26,770,127,954 27,464,045,923

, Plant and Equipment 18,271,557,962 20,760,435,864 20,567,202,390

27,196,589,272 38,291,544,874 46,886,757,989

3,642,090,783 4,596,512,673 5,687,406,329
d Other Receivables 1,587,211,300 1,561,818,167 1,520,300,337
s, Deposits and Prepayments 2,131,347,122 2,272,974,744 2,560,646,884
d Cash Equivalents 16,703,964,704 26,923,168,224 32,233,314,319

53,329,313,432 65,061,672,828 74,350,803,912

& LIABILITIES:
ders’ Equity 46,662,876,378 60,806,054,977 69,909,802,046
7,373,910,900 7,890,084,660 8,442,390,580
0 2,211,743,936 2,211,743,936
105,878,200 105,878,200 105,878,200
36,931,891,345 48,417,297,898 57,507,130,053
2,035,465,000 2,035,465,000 2,035,465,000

rent Liabilities 1,126,645,973 1,294,346,873 1,212,928,798

Tax Liabilities 1,126,645,973 1,294,346,873 1,212,928,798

5,539,791,081 2,961,270,978 3,228,073,068

4,414,979,709 708,882,266 541,067,905

s for Other Finance 1,035,189,330 2,014,186,770 2,228,332,123
s for Expenses 89,622,042 238,201,942 128,241,317
ed Dividend 0 0 330,431,723

uity and Liabilities 53,329,313,432 65,061,672,828 74,350,803,912

t Value (NAV) Per Share 59.14 77.07 78.86

 Olympic Industries Limited
Income Statement
For the year ended June 30

Revenue
Cost of Sales
Gross Profit

Administrative Expenses
Selling Expenses
Operating Expenses

Profit from Operations

Finance Cost
Other Income
Profit /(Loss) for the year
Net changes in fair value of investmen

Contribution to WPPF and Welfare Fund

Profit Before Tax

Income Tax Expenses

Current Tax
Deferred Tax

Net Profit after taxation

Marlet price per share

Number of share outstanding
Earnings Per Share (EPS)
 Olympic Industries Limited
Ratio Analysis
For the year ended June 30

Liquidity Ratios
Current Ratio x Current Asset/Current Liabilities
Quick Ratio x (Current Asset – Inventories)/Curre
Asset Management Ratios
Inventory Turnover x COGS/Inventory
Recievable Turnover/Average Collection Period Days Receivables / Annual sales/365
Average Payment Period Days Payables / Annual purchases/365
Total Asset Turnover x Sales/Total Assets
Fixed Asset Turnover x Sales/Net Fixed Asset
Profitability Ratios
Gross Profit Margin % Gross profit/ Sales
Operating Profit Margin % EBIT/ Sales
Net Profit Margin % Net Income After Tax / Net Sales
Basic Earnings Power (BEP) % EBIT/Total Assets
Return on Asset (ROA) % Net Income After Tax / Total Asse
Return on Equity (ROE) % Net Inc. After Tax/Stockholders E
Earnings Per Share (EPS) % N.I/ number of share of common
Debt Management Ratios
Debt Ratio % Total debt / Total assets
Times Interest Earned (TIE) x EBIT / Interest expense
Market Ratios
Price/Earnings Ratio (P/E) % Mkt. Price Per Share/EPS
Market to Book Ratio (M/B) % Market price per share/Book valu
Olympic Industries Limited
Income Statement
For the year ended June 30

2020 2019 2018 2017

15,895,037,599 13,733,728,376 12,928,501,078 11,290,557,541

-10,826,540,639 -9,185,337,984 -8,707,718,622 -7,523,115,147
5,068,496,960 4,548,390,392 4,220,782,456 3,767,442,394

-358,910,484 -323,362,429 -328,563,859 -292,089,909

-2,055,657,417 -1,716,042,222 -1,497,230,341 -1,322,222,891
-2,414,567,901 -2,039,404,651 -1,825,794,200 -1,614,312,800

2,653,929,059 2,508,985,741 2,394,988,256 2,153,129,594

-171,130,249 -194,338,696 -155,519,117 -118,234,767
425,800,621 366,579,768 285,926,925 299,186,803
2,908,599,431 2,681,226,813 2,525,396,064 2,334,081,630
-3,920,630 -2,086,699 -5,777,080 -157,010
2,904,678,801 2,679,140,114 2,519,618,984 2,333,924,620
-138,318,038 -127,578,101 -119,981,856 -111,139,268

2,766,360,763 2,551,562,013 2,399,637,128 2,222,785,352

-741,406,548 -679,740,453 -608,569,508 -579,534,678

-699,484,660 -659,194,593 -592,843,349 -565,599,025
-41,921,888 -20,545,860 -15,726,159 -13,935,653

2,024,954,215 1,871,821,560 1,791,067,620 1,643,250,674

2020 2019 2018 2017

30-Jun 30-Jun 28-Jun 29-Jun
150.20 236.30 224.40 278.50
199938886.00 199938886.00 199938886.00 199938886.00
10.13 9.36 8.96 8.22
ustries Limited
Analysis
ended June 30
2020 2019 2018 2017

2.49 2.22 1.90 1.98

1.93 1.82 1.57 1.72

(6.17) (7.33) (6.66) (8.46)

8.30 5.61 5.04 5.28
24.43 23.68 24.05 29.30
1.35 1.25 1.20 1.24
4.01 3.52 4.07 4.78

31.89% 33.12% 32.65% 33.37%

16.70% 18.27% 18.52% 19.07%
12.74% 13.63% 13.85% 14.55%
22.49% 22.90% 22.14% 23.61%
17.16% 17.08% 16.56% 18.02%
24.57% 25.94% 28.41% 30.36%
10.13 9.36 8.96 8.22

1.96% 3.79% 3.39% 2.10%

15.51 12.91 15.4 18.21

14.83 25.25 25.04 33.88

3.64 6.55 7.12 10.29
 Olympic Industries Limited
Balance Sheet
For the year ended June 30

2020 2019 2018

ASSETS
Non-current Assets:
Property, Plant & Equipment 3,154,940,982 2,754,848,741 2,243,553,821
Intangible Assets -Software ERP 1 1 1
Right-of-Use Asset (ROU), Net 48,907,381 0 0
Capital Work-in-Progress 762,173,394 1,144,215,357 930,608,133

Current Assets:
Inventories 1,754,377,814 1,253,065,390 1,306,910,332
Trade & Other Receivables 361,539,012 211,109,972 178,459,954
Advances, Deposits & Pre-payments 817,755,640 970,952,183 1,725,403,875
Investments 4,227,541,203 4,014,955,674 3,970,700,921
Cash & Cash Equivalents 675,271,818 608,038,640 461,316,250
7,836,485,487 7,058,121,859 7,642,791,332

Total Assets 11,802,507,245 10,957,185,958 10,816,953,287

EQUITY & LIABILITIES

Shareholders’ Equity:
Share Capital 1,999,388,860 1,999,388,860 1,999,388,860
Retained Earnings 6,242,179,551 5,216,919,766 4,304,804,859
8,241,568,411 7,216,308,626 6,304,193,719

Non-current Liabilities:
Long-Term loan - Non- Current Portion 200,451,144 415,266,729 361,912,071
Lease Finance - Non- Current Portion 31,314,817 0 4,634,269
Deferred Tax Liability 185,897,673 143,975,785 123,429,925
417,663,634 559,242,514 489,976,265

Total Equity & Non - Current Liabilities 8,659,232,045 7,775,551,140 6,794,169,984

Current Liabilities & Provisions:

Short-Term Loans and Overdraft 1,153,021,184 1,411,757,914 1,571,406,579
Long-Term Loan-Current Portion 379,397,855 240,191,007 174,225,982
Lease Finance-Current Portion 19,039,088 4,949,584 9,248,053
Interest Payable 845,829 367,531 98,923
Creditors for Goods 564,234,655 463,198,318 456,418,351
Creditors for Services 8,707,741 2,856,018 12,580,993
Accrued Expenses 151,842,589 129,827,919 104,782,112
Advance Against Sales 237,997,725 246,596,537 87,988,924
Liabilities for Other Finance 106,470,600 74,502,706 94,875,855
Provision for Current Tax 66,362,174 175,086,506 1,149,733,308
Unclaimed Dividend 255,625,820 205,720,139 160,773,483
Employee Benefit Obligations 199,729,940 226,580,639 200,650,740
3,143,275,200 3,181,634,818 4,022,783,303

Total Liabilities 3,560,938,834 3,740,877,332 4,512,759,568

Total Equity & Liabilities 11,802,507,245 10,957,185,958 10,816,953,287

 2017

1,907,118,367
6,452,865
0
450,255,126

889,663,238
163,380,305
1,360,608,025
4,095,492,162
247,347,709
6,756,491,439

9,120,317,797

1,999,388,860
3,413,462,226
5,412,851,086

176,148,442
14,971,692
107,703,766
298,823,900

5,711,674,986

846,439,265
144,803,219
25,410,811
406,227
529,203,787
15,780,537
 58,898,027
131,633,278
53,816,000
1,138,136,995
111,632,675
352,481,990
3,408,642,811

3,707,466,711

9,120,317,797
FU-WANG F
Pos
 FU-WANG FOODS
Financial Position &
2019
Links: FU-WANG FOODS LTD.
https://www.fuwangfoodsltd.com/public/front/pdf/16081915544.pdf

https://www.fuwangfoodsltd.com/public/front/pdf/15440784634.pdf
FU-WANG FOODS LTD. Statement of Financial
Position & Income Statement.
2017 & 2018
 FU-WANG FOODS LTD. Statement of
Financial Position & Income Statement.
2019 & 2020
Olympic Industries lim
Financial Position & In
2017 & 2
Olympic Industries lim
Financial Position &
2019 &
Links: Olympic Industries limited
http://olympicbd.com/financials-annual-report/
lympic Industries limited Statement of
nancial Position & Income Statement.
2017 & 2018
Olympic Industries limited Statement of
Financial Position & Income Statement
2019 & 2020